Tris Pharma, Inc., a specialty pharmaceutical company, researches, develops, manufactures, and markets over-the-counter, Rx branded, and specialty generic products in the United States. The company develops extended release formulations for products intended for children, seniors, and adults who have difficulty swallowing pills and require multi-dose treatment. It also offers OralXR+, a particulate-based technology in which millions of small particles deliver the drug over time; Nobuse, an abuse resistant proprietary technology; and specialty generic products in immediate and extended release versions.
The following is the list of scholars from Tris Pharma Inc who contributed and/or serves as editors for one or more OMICS International journals and conferences
The following is the list of articles by scholars from Tris Pharma Inc that are published in OMICS International journals.